首页> 外文期刊>British Journal of Obstetrics and Gynaecology >Delivery outcome after the use of acid-suppressing drugs in early pregnancy with special reference to omeprazole.
【24h】

Delivery outcome after the use of acid-suppressing drugs in early pregnancy with special reference to omeprazole.

机译:妊娠早期使用抑酸药物后的分娩结局,特别参考奥美拉唑。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To study delivery outcome after maternal use of acid-suppressing drugs during early pregnancy. DESIGN: Cohort study of women identified by interview in early pregnancy. POPULATION: Sweden women giving birth from 1995 to early 1997. METHODS: Comparison of infants exposed to acid-suppressing drugs with all births in 1995-1996. MAIN OUTCOME MEASURES: Presence of congenital malformations. RESULTS: Proton pump blockers were used by 275 women, H2 receptor antagonists by 255 women, and both categories of drugs by 20 women. No effect of the use of omeprazole or H2-receptor antagonists on the rate of congenital malformations could be demonstrated. CONCLUSIONS: Though a teratogenic effect of these drugs cannot be completely ruled out, the individual risk after exposures during the first trimester seems to be negligible.
机译:目的:研究孕早期母体使用抑酸药物后的分娩结局。设计:对早期妊娠中通过访谈确定的女性进行的队列研究。人口:瑞典妇女于1995年至1997年初分娩。方法:比较1995年至1996年接受抗酸药物治疗的婴儿与所有婴儿的出生情况。主要观察指标:先天性畸形的存在。结果:275名妇女使用了质子泵阻滞剂,255名妇女使用了H2受体拮抗剂,20名妇女使用了这两种药物。没有证明使用奥美拉唑或H2受体拮抗剂对先天性畸形的发生率有影响。结论:尽管不能完全排除这些药物的致畸作用,但在头三个月暴露后的个体风险似乎可以忽略不计。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号